Effect of Resveratrol Dry Suspension on Immune Function of Piglets
Table 1
Growth performance and visceral index.
Items
Group I
Group II
Group III
Group IV
Group V
Initial body weight (kg)
6.52 ± 0.07
6.52 ± 0.18
6.75 ± 0.41
6.57 ± 0.38
6.61 ± 0.16
Final body weight (kg)
7.82 ± 0.37
7.65 ± 0.31
8.5 ± 0.4
8.13 ± 0.75
8.41 ± 0.13
Average daily feed intake (g)
242.86 ± 23.26
193.33 ± 12.03
248.07 ± 42.6
183.34 ± 33.35
128.09 ± 3.92
Average daily gain (g)
93.33 ± 29.65
80.95 ± 9.71
149.05 ± 27.64
111.9 ± 27.92
226.45 ± 26.95
Ratio of feed to gain
3.25 ± 1.04
2.42 ± 0.16
1.67 ± 0.03
1.68 ± 0.17
1.78 ± 0.24
Heart coefficient
5.37 ± 0.34
4.99 ± 0.24
5.45 ± 0.27
5.18 ± 0.11
5.51 ± 0.39
Lung coefficient
27.32 ± 2.52
26.5 ± 1.92
24.28 ± 2.05
24.47 ± 1.73
20.67 ± 1.25
Liver coefficient
27.32 ± 2.52
26.5 ± 1.92
24.28 ± 2.05
24.47 ± 1.73
20.67 ± 1.25
Kidney coefficient
5.94 ± 0.49
6.05 ± 0.18
6.3 ± 0.54
5.62 ± 0.22
6.11 ± 0.34
Spleen coefficient
1.94 ± 0.14
1.52 ± 0.18
1.68 ± 0.04
1.52 ± 0.16
2.01 ± 0.19
Lymph nodes coefficient
1.45 ± 0.13
1.84 ± 0.26
1.76 ± 0.22
1.44 ± 0.15
1.63 ± 0.16
Group I, saline control; Group II, RDS 0.1 g/kg treated group; Group III, RDS 0.33 g/kg treated group; Group IV, RDS 1.0 g/kg treated group; Group V, Echinacea purpurea powder 0.05 g/kg treated group. Data are represented as means ± SE; ; comparison was made with the model group; one-way ANOVA followed by Duncan test.
